NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

They are shorting because they know that this company has nothing meaningful up their sleeve and they will go nowhere. No institutional investors or big pharma are backing them financially.

Plus, they won’t be making any meaningful revenue from UK over the next couple of years post approval.

Endless dilution in store and it’s easy money for them. We are still trading at around $300M market cap. That’s very rich valuation for a company even post UK approval with such a pathetic management team that has a history of losing shareholder value for over 15 years in a row.